Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1/A IPO registration
- 1.1 Form of Underwriting Agreement
- 3.1 Certificate of Incorporation
- 3.2 Certificate of Amendment to the Certificate of Incorporation
- 3.3 Bylaws of Unicycive Therapeutics, Inc
- 5.1 Opinion of Sheppard, Mullin, Richter & Hampton LLP
- 10.1 2018 Equity Incentive Plan
- 10.2 2019 Stock Option Plan
- 10.4 Assignment and Asset Purchase Agreement by and Between the Company and Spectrum Pharmaceuticals, Inc., Dated September 20, 2018
- 10.5 Exclusive License Agreement by and Between the Company and Sphaera Pharma Pte. LTD., Dated October 1, 2017
- 10.6 Service Agreement by and Between the Company and Globavir Biosciences, Inc. Dated July 1, 2017
- 23.1 Consent of Mayer Hoffman Mccann P.C., Independent Registered Public Accounting Firm
- 99.1 Consent of Brigitte Schiller, M.D. to Be Named As a Director Upon Completion of the Offering
Associated filings
- 14 Jul 21 424B4 Prospectus supplement with pricing info
- 13 Jul 21 EFFECT Notice of effectiveness
- 12 Jul 21 S-1/A IPO registration (amended)
- 12 Jul 21 S-1/A IPO registration (amended)
- 30 Jun 21 S-1/A IPO registration (amended)
- 21 Jun 21 S-1/A IPO registration (amended)
-
7 Jun 21 S-1/A IPO registration (amended)
- 21 May 21 S-1 IPO registration
UNCY similar filings
Filing view
External links
Exhibit 99.1
CONSENT OF DIRECTOR NOMINEE
In accordance with Rule 438 under the Securities Act of 1933, as amended, the undersigned hereby consents to being named as a nominee to the board of directors of Unicycive Therapeutics Inc., a Delaware corporation (the “Company”), in the Company’s registration statement on Form S-1 and in all amendments thereto, including post-effective amendments (the “Registration Statement”), in connection with the initial public offering of the Company’s common stock. The undersigned also consents to the filing of this consent as an exhibit to such Registration Statement and any amendments thereto.
Dated: May 25, 2021 | |
/s/ Brigitte Schiller, M.D. | |
Brigitte Schiller, M.D. |